Your browser doesn't support javascript.
loading
Concomitant ALK translocation and EGFR C797S mutation as resistance mechanisms to osimertinib in an EGFR-mutant NSCLC patient.
Pons-Tostivint, Elvire; Hulo, Pauline; Sagan, Christine; Papazyan, Thomas; Herbreteau, Guillaume; Denis, Marc.
Affiliation
  • Pons-Tostivint E; Nantes University, Centre Hospitalier Universitaire Nantes, Medical oncology, F-44000 Nantes, France; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France. Electronic address: elvire.pons@chu-nantes.fr.
  • Hulo P; Nantes University, Centre Hospitalier Universitaire Nantes, Medical oncology, F-44000 Nantes, France; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.
  • Sagan C; Nantes University, Centre Hospitalier Universitaire Nantes, Pathology department, F-44000 Nantes, France.
  • Papazyan T; Nantes University, Centre Hospitalier Universitaire Nantes, Medical oncology, F-44000 Nantes, France.
  • Herbreteau G; Nantes University, Centre Hospitalier Universitaire Nantes, Department of Bichemistry, F-44000 Nantes, France.
  • Denis M; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France; Nantes University, Centre Hospitalier Universitaire Nantes, Department of Bichemistry, F-44000 Nantes, France.
Respir Med Res ; 86: 101116, 2024 May 14.
Article in En | MEDLINE | ID: mdl-38843599
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Respir Med Res Year: 2024 Document type: Article Country of publication: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Respir Med Res Year: 2024 Document type: Article Country of publication: Francia